Vaccination will be key to keeping patients healthy through the winter holidays
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
Asthma Exacerbations Up After Relaxation of COVID-19 Restrictions
Relaxation of restrictions coincided with increasing incidence of COVID-19, non-COVID-19 ARI, severe asthma exacerbations
Severe Outcomes From COVID-19 Up With Preexisting Neuropsych Conditions
Neuropsychiatric conditions and/or associated treatment linked to increased risk for severe outcomes from COVID-19, SARIs
Physicians Say Faulty Oxygen Devices Put Lives in Peril
Speaking to an expert panel during an FDA hearing, physicians cast doubt on the accuracy of pulse oximeters
Change Seen in Pediatric Respiratory Infection Trends After SARS-CoV-2 Emergence
During April 2020 to May 2021, many respiratory viruses circulated at lower-than-expected levels
Pirfenidone Promising for RA-Linked Interstitial Lung Disease
Phase 2 trial terminated early, underpowered to meet primary end point, but limited results suggest pirfenidone may slow progression of RA-ILD
Persistent Pulmonary Dysfunction Seen in Children After COVID-19
Persistent pulmonary dysfunction seen for those who have recovered from COVID-19 and with long COVID
Survival Benefit With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay
Survival Benefit Seen With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay